Current status of Cancer Nanotheranostics: Emerging strategies for cancer management

Cancer diagnosis and management have been a slow-evolving area in medical science. Conventional therapies have by far proved to have various limitations. Also, the concept of immunotherapy which was thought to revolutionize the management of cancer has presented its range of drawbacks. To overcome these limitations nanoparticulate-derived diagnostic and therapeutic strategies are emerging. These nanomaterials are to be explored as they serve as a prospect for cancer theranostics. Nanoparticles have a significant yet unclear role in screening as well as therapy of cancer. However, nanogels and Photodynamic therapy is one such approach to be developed in cancer theranostics. Photoactive cancer theranostics is a vivid area that might prove to help manage cancer. Also, the utilization of the quantum dots as a diagnostic tool and to selectively kill cancer cells, especially in CNS tumors. Additionally, the redox-sensitive micelles targeting the tumor microenvironment of the cancer are also an important theranostic tool. This review focuses on exploring various agents that are currently being studied or can further be studied as cancer theranostics.

[1]  Vivek P. Chavda,et al.  Antibody–Biopolymer Conjugates in Oncology: A Review , 2023, Molecules.

[2]  Vivek P. Chavda,et al.  Nanotheranostics-based Management of Head and Neck Cancer , 2023, Nanotheranostics.

[3]  Vivek P. Chavda,et al.  Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer , 2023, Cancers.

[4]  Vivek P. Chavda,et al.  Propolis and Their Active Constituents for Chronic Diseases , 2023, Biomedicines.

[5]  Vivek P. Chavda,et al.  Interventional nanotheranostics in hepatocellular carcinoma , 2023, Nanotheranostics.

[6]  Akash Kumar,et al.  Role of Tunable Gold Nanostructures in Cancer Nanotheranostics: Implications on Synthesis, Toxicity, Clinical Applications and Their Associated Opportunities and Challenges , 2023, Journal of Nanotheranostics.

[7]  Vivek P. Chavda,et al.  Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer , 2023, Cancers.

[8]  Vivek P. Chavda,et al.  mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics , 2022, Vaccines.

[9]  Vivek P. Chavda,et al.  An Impact of COVID-19 on Cancer Care: An Update , 2022, Vaccines.

[10]  P. Mathur,et al.  Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India , 2022, The Indian journal of medical research.

[11]  Vivek P. Chavda,et al.  Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges , 2022, Frontiers in Oncology.

[12]  Vivek P. Chavda,et al.  Phytochemical-loaded liposomes for anticancer therapy: an updated review. , 2022, Nanomedicine.

[13]  A. Ojha,et al.  Nanotheranostics: Nanoparticles Applications, Perspectives, and Challenges , 2021, BioSensing, Theranostics, and Medical Devices.

[14]  Wen-jun Wang,et al.  NIR-II Organic Nanotheranostics for Precision Oncotherapy. , 2021, Small.

[15]  Jun Wu.  The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application , 2021, Journal of personalized medicine.

[16]  N. Jain,et al.  Nanoengineered photoactive theranostic agents for cancer , 2021, Nanophotonics.

[17]  V. Mishra,et al.  Dendrimers based cancer nanotheranostics: An overview. , 2021, International journal of pharmaceutics.

[18]  Leaf Huang,et al.  mRNA vaccine for cancer immunotherapy , 2021, Molecular cancer.

[19]  D. Shahbazi-Gahrouei,et al.  Recent nanotheranostics applications for cancer therapy and diagnosis: A review , 2021, IET nanobiotechnology.

[20]  B. Manshian,et al.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors , 2021, Chemical reviews.

[21]  Evren Gundogdu,et al.  Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities , 2020, Asian journal of pharmaceutical sciences.

[22]  A. Rengan,et al.  Aptamer-Mediated Nanotheranostics for Cancer Treatment: A Review , 2020 .

[23]  Atiah H. Almalki,et al.  Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine , 2020, Cancers.

[24]  T. Minko,et al.  Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery , 2020, Expert opinion on drug delivery.

[25]  Sarkar Siddique,et al.  Application of Nanomaterials in Biomedical Imaging and Cancer Therapy , 2020, Nanomaterials.

[26]  H. Ueno,et al.  Highly reliable, targeted photothermal cancer therapy combined with thermal dosimetry using a near-infrared absorbent , 2020, Scientific Reports.

[27]  R. Pani,et al.  New Frontiers in Molecular Imaging with Superparamagnetic Iron Oxide Nanoparticles (SPIONs): Efficacy, Toxicity, and Future Applications , 2020, Nuclear Medicine and Molecular Imaging.

[28]  Wei R. Chen,et al.  Monitoring tissue temperature during photothermal therapy for cancer. , 2019, Journal of bio-X research.

[29]  Pedro Pedrosa,et al.  Nanotheranostics Targeting the Tumor Microenvironment , 2019, Front. Bioeng. Biotechnol..

[30]  Amir Khorasani,et al.  A literature review on multimodality molecular imaging nanoprobes for cancer detection , 2019, Polish Journal of Medical Physics and Engineering.

[31]  D. Shahbazi-Gahrouei,et al.  Medical imaging modalities using nanoprobes for cancer diagnosis: A literature review on recent findings , 2019, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[32]  Z. Dai,et al.  Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. , 2019, Chemical Society reviews.

[33]  J. Lovell,et al.  Metalloporphyrin Nanoparticles: Coordinating Diverse Theranostic Functions. , 2017, Coordination chemistry reviews.

[34]  Abhalaxmi Singh,et al.  Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis. , 2019, Anti-cancer agents in medicinal chemistry.

[35]  Leonardo Fernandes Fraceto,et al.  Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.

[36]  Behzad Baradaran,et al.  Targeted detection of the cancer cells using the anti-CD24 bio modified PEGylated gold nanoparticles: the application of CD24 as a vital cancer biomarker , 2018 .

[37]  J. Qu,et al.  Phasor-Fluorescence Lifetime Imaging Microscopy Analysis to Monitor Intercellular Drug Release from a pH-Sensitive Polymeric Nanocarrier. , 2018, Analytical chemistry.

[38]  S. Vermeire,et al.  The intestinal barrier: a fundamental role in health and disease , 2017, Expert review of gastroenterology & hepatology.

[39]  Kapil D. Patel,et al.  Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles. , 2017, Acta biomaterialia.

[40]  Xiaoyuan Chen,et al.  Rethinking cancer nanotheranostics. , 2017, Nature reviews. Materials.

[41]  Miles A. Miller,et al.  Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior. , 2017, Advanced drug delivery reviews.

[42]  T. Park,et al.  Diverse Applications of Nanomedicine , 2017, ACS nano.

[43]  Prakash Rai,et al.  Remotely Triggered Nano-Theranostics For Cancer Applications , 2017, Nanotheranostics.

[44]  Jonathan F. Lovell,et al.  Targeted Nanomaterials for Phototherapy , 2017, Nanotheranostics.

[45]  Ligeng Xu,et al.  Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy , 2016, Nature Communications.

[46]  I. Kwon,et al.  Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy , 2016, Theranostics.

[47]  J. Zink,et al.  Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[48]  W. Ran,et al.  Recent Progress in Light-Triggered Nanotheranostics for Cancer Treatment , 2016, Theranostics.

[49]  Dan Wang,et al.  Hyaluronic acid-coated poly(β-amino) ester nanoparticles as carrier of doxorubicin for overcoming drug resistance in breast cancer cells , 2016 .

[50]  D. Xing,et al.  Imaging-guided photoacoustic drug release and synergistic chemo-photoacoustic therapy with paclitaxel-containing nanoparticles. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[51]  Heidi Abrahamse,et al.  New Photosensitizers For Photodynamic Therapy , 1990, [1990] Proceedings of the Twelfth Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[52]  Ashley M. Laughney,et al.  Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle , 2015, Science Translational Medicine.

[53]  Magdalena Bazalova-Carter,et al.  Molecular Magnetic Resonance Imaging of Tumor Response to Therapy , 2015, Scientific Reports.

[54]  Jibin Song,et al.  Sequential Drug Release and Enhanced Photothermal and Photoacoustic Effect of Hybrid Reduced Graphene Oxide-Loaded Ultrasmall Gold Nanorod Vesicles for Cancer Therapy. , 2015, ACS nano.

[55]  Ash A. Alizadeh,et al.  Toward understanding and exploiting tumor heterogeneity , 2015, Nature Medicine.

[56]  M. Ferrari,et al.  Intravital Microscopy Imaging Approaches for Image-Guided Drug Delivery Systems. , 2015, Current drug targets.

[57]  Huixin He,et al.  Phthalocyanine-loaded graphene nanoplatform for imaging-guided combinatorial phototherapy , 2015, International journal of nanomedicine.

[58]  Feng Chen,et al.  Nanomedicine for targeted photothermal cancer therapy: where are we now? , 2015, Nanomedicine.

[59]  Ick Chan Kwon,et al.  pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers. , 2015, ACS nano.

[60]  Brian L Sprague,et al.  Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts. , 2015, American journal of obstetrics and gynecology.

[61]  Tingting Li,et al.  Multifunctional Core/Shell Nanoparticles Cross-linked Polyetherimide-folic Acid as Efficient Notch-1 siRNA Carrier for Targeted Killing of Breast Cancer , 2014, Scientific Reports.

[62]  Zhuang Liu,et al.  Engineering of Multifunctional Nano‐Micelles for Combined Photothermal and Photodynamic Therapy Under the Guidance of Multimodal Imaging , 2014 .

[63]  J. G. Solé,et al.  Nanoparticles for photothermal therapies. , 2014, Nanoscale.

[64]  K. Chatterjee,et al.  Core/shell nanoparticles in biomedical applications. , 2014, Advances in colloid and interface science.

[65]  Y. Omidi,et al.  Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines , 2014, BioImpacts : BI.

[66]  Lin Mei,et al.  The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment. , 2014, Biomaterials.

[67]  Yu Cheng,et al.  Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma☆ , 2013, Biomaterials.

[68]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[69]  O. Taratula,et al.  A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy. , 2013, Molecular pharmaceutics.

[70]  S. Perrier,et al.  Monodisperse, Charge-Stabilized, Core–Shell Particles via Silica-Supported Reversible Addition–Fragmentation Chain Transfer Polymerization for Cell Imaging , 2013 .

[71]  C. Sung,et al.  Nanocomposite liposomes containing quantum dots and anticancer drugs for bioimaging and therapeutic delivery: a comparison of cationic, PEGylated and deformable liposomes , 2013, Nanotechnology.

[72]  Rajan Jain,et al.  Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications , 2013, NMR in biomedicine.

[73]  Tiantian Kong,et al.  Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release. , 2013, Acta biomaterialia.

[74]  A. Payne,et al.  Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model , 2013, Journal of therapeutic ultrasound.

[75]  Zhe Wang,et al.  Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. , 2013, ACS nano.

[76]  Toshio Matsumoto,et al.  Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment , 2013, Theranostics.

[77]  Jeong Yu Lee,et al.  Optically Traceable Solid Lipid Nanoparticles Loaded with siRNA and Paclitaxel for Synergistic Chemotherapy with In situ Imaging , 2013, Advanced healthcare materials.

[78]  M. S. Muthu,et al.  Copolymers of poly(lactic acid) and d-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy , 2013, Expert opinion on drug delivery.

[79]  Kai Jiang,et al.  Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents. , 2013, Journal of materials chemistry. B.

[80]  Hong Ding,et al.  Image Guided Biodistribution and Pharmacokinetic Studies of Theranostics , 2012, Theranostics.

[81]  Marek Romanowski,et al.  Light-Activated Content Release from Liposomes , 2012, Theranostics.

[82]  R. Kumar,et al.  In Vitro Evaluation of Theranostic Polymeric Micelles for Imaging and Drug Delivery in Cancer , 2012, Theranostics.

[83]  James F. Leary,et al.  Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. , 2012, Biomaterials.

[84]  Si-Shen Feng,et al.  Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. , 2012, Biomaterials.

[85]  Yin Zhang,et al.  Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. , 2012, Biomaterials.

[86]  Sang-Jun Park,et al.  Gold half-shell coated hyaluronic acid-doxorubicin conjugate micelles for theranostic applications , 2012, Macromolecular Research.

[87]  T. Yen,et al.  Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging , 2012, International journal of nanomedicine.

[88]  Takeshi Kobayashi,et al.  Cancer hyperthermia using magnetic nanoparticles , 2011, Biotechnology journal.

[89]  Ick Chan Kwon,et al.  Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. , 2011, Biomaterials.

[90]  Danielle Rand,et al.  Nanomaterials for X-ray imaging: gold nanoparticle enhancement of X-ray scatter imaging of hepatocellular carcinoma. , 2011, Nano letters.

[91]  Jun Ding,et al.  Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles. , 2011, Biomaterials.

[92]  Y. Jeong,et al.  A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. , 2010, ACS nano.

[93]  S. Feng,et al.  Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment. , 2010, Nanomedicine.

[94]  Silvio Aime,et al.  Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma. , 2010, Cancer research.

[95]  P. Ang,et al.  Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[96]  G. J. Fleer,et al.  Advances in Colloid and Interface Science , 2010 .

[97]  R. Bellamkonda,et al.  Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. , 2009, Radiology.

[98]  M. S. Muthu,et al.  Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. , 2009, Nanomedicine.

[99]  Sandra Geyser-Stoops,et al.  Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulation. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[100]  T. Minko,et al.  Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[101]  Sangjin Park,et al.  Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. , 2008, Angewandte Chemie.

[102]  Jie Chen,et al.  Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles. , 2008, Clinical and investigative medicine. Medecine clinique et experimentale.

[103]  Wolfgang A. Weber,et al.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.

[104]  Guido Bocci,et al.  Drug distribution in tumors: Mechanisms, role in drug resistance, and methods for modification , 2007, Current oncology reports.

[105]  Anna Moore,et al.  In vivo imaging of siRNA delivery and silencing in tumors , 2007, Nature Medicine.

[106]  Xiao-bing Xiong,et al.  Polymeric micelles for drug targeting , 2007, Journal of drug targeting.

[107]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[108]  P. Wust,et al.  The cellular and molecular basis of hyperthermia. , 2002, Critical reviews in oncology/hematology.

[109]  C A Carlsson,et al.  Imaging modalities in x-ray computerized tomography and in selected volume tomography , 1999, Physics in medicine and biology.

[110]  L. Murray,et al.  Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.